establish lab hold inc found
headquart alajuela costa rica
global innov market proprietari
devic suppli
billion
global augment reconstruct breast implant
commerci sale outsid unit state
sold countri top
market fda approv expect earli
reason report
estim chang analysi sales/earn
reiter o/v invest rate price target
esta share encourag investor look next
month period tribul accumul esta share
rel absolut discount posit high
growth favor margin industri leader longer term
realiz share gain exhibit organ revenu growth
excess enhanc margin profil materi reduc
burn rate also secur key patent shepherd
regulatori process forward simpli put continu favor esta
posit within aesthet reconstruct marketplac view
compani long-term winner high margin privat pay
segment accordingli reiter o/v invest rate
month price target esta share
maintain price price target
esta share remain unchang recal price target
assum conserv revenu multipl
due disrupt natur compani portfolio despit
highli discretionari natur
chang estim fine-tun
revenu earn estim reflect compani solid
oper result increment commentari relat outlook
balanc specif revis former
million revenu loss estim million
per share respect likewis former revenu
loss estim million revis
million per share
corpor guidanc suspend esta previous abstain
provid financi guidanc conjunct compani
march pre-announc continu forgo guidanc pend
greater clariti sever durat impact
industri
aesthet pleas valuat esta share current
trade revenu impli notabl rel discount
compar emerg growth med tech industri peer trade
like multipl opinion despit discretionari natur
esta disrupt product offer impli rel discount
great creat attract rel risk/reward set-up
import disclosur analyst certif page report access current disclosur stephen
inc cover compani client may refer
product pipelin on-track importantli esta reiter compani timelin pma submiss fda
aesthet cohort remain track result continu expect domest commerci exit
recal esta pursu bifurc file strategi fda end surgeri aesthet augment
cohort complet progress continu reconstruct cohort though slower rate due
like quarter delay end esta announc compani plan first seek approv
augment indic subsequ file reconstruct indic addit compani disrupt tissu
expand technolog flora continu progress expect commenc european commerci
notabl quarter esta achiev yet anoth record quarter sale mark seventh consecut
quarter record revenu result despit materi global headwind surgeon increasingli migrat
compani proprietari smooth surfac technolog implant within framework direct sale eas modestli
quarter account total revenu versu oper period sale brazil
world second-largest breast aesthet market account total revenu total sale
importantli women brazil select esta motiva opt top defer rather
cancel procedur due limit cost perspect esta implement action reduc
oper expens year year preserv liquid alloc capit growth relat function
balanc sheet review esta exit oper period million cash cash equival total
debt million net cash posit million equival net cash per share importantli cash
use oper total million versu million prior-year period repres reduct
histor project financi
remain o/v esta organ growth temporarili forecast return top tier level coupl margin expans
motiva remain clinic differenti augment reconstruct offer industri
result look esta share rebound faster peer women increasingli seek safer natur appear option
motiva clinic differenti potenti posit esta faster return normal concern subsid
balanc sheet provid suffici liquid success fund growth continu busi develop
geograph divers sale mix materi exposur potenti hedg econom depress risk key market
addit cost reduct enhanc st liquid enhanc margin profil lt
histor project financi
motiva fda clinic trial enrol submiss delay push new product timelin quarter
near-term risk remain durat impact consum remain unknown
discretionari purchas could advers affect declin incom brought global shutdown
close stock price may
note million except per share data
compani document stephen inc estim
million except per share data
good sold
research develop
sell gener
incom tax
note million except per share data
compani document stephen inc estim
note million except per share data
compani document stephen inc estim
figur estim revis summari consensu comparison
mil except ep actual
mil except ep
note million except per share data
compani document stephen inc estim
fiscal period
fiscal period
consolid statement incom
oper period
million except per share data
revenu
sale gener administr
research develop
chang fair valu deriv instrument
chang fair valu conting consider
total expens
incom loss prior incom tax
provis incom tax
margin analysi express total revenu
research develop
compani document stephen inc
analyst primarili respons prepar content report certifi view express report
accur reflect analyst person view subject compani secur ii part analyst compens
directli indirectli relat specif recommend view express analyst report
